45 Participants Needed

Psychotherapy for Depression

FF
ZS
Overseen ByZachary Stewart
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: University of North Carolina, Chapel Hill
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it does exclude participants who take more than 20 mg of benzodiazepines daily. It's best to discuss your specific medications with the study team.

What data supports the effectiveness of the treatment Behavioral Activation for depression?

Research shows that Behavioral Activation (BA) is an effective treatment for depression, with studies highlighting its success as a standalone therapy. It involves techniques like activity scheduling and skills training, which have been proven to help improve depressive symptoms.12345

Is psychotherapy for depression, including Behavioral Activation and similar therapies, generally safe for humans?

The research articles provided do not contain specific safety data for psychotherapy treatments like Behavioral Activation or similar therapies for depression. However, they discuss the importance of risk assessment and safety models in behavior analysis, which suggests that safety is a considered aspect in the field.678910

How is Behavioral Activation different from other treatments for depression?

Behavioral Activation (BA) is unique because it focuses on helping people engage in activities that bring them pleasure or a sense of achievement, which can improve mood and motivation. Unlike some therapies that require extensive psychological training, BA can be delivered by practitioners with less training, making it accessible in low-resource settings.15111213

What is the purpose of this trial?

The goal of this study is to learn the extent to which client-therapist brain activity may synchronize during a psychosocial intervention for depression symptoms.The study will compare behavioral activation, a client-centered type of cognitive-behavioral therapy, to psychoeducation which delivers information on strategies to recover from depression symptoms.Participants will answer questions about their mental and physical health, attend one psychosocial intervention session receiving either Behavioral Activation or Psychoeducation with simultaneous brain activity measurement and complete follow up surveys two weeks and one month following the intervention.

Research Team

FF

Flavio Frohlich

Principal Investigator

Carolina Center for Neurostimulation

Eligibility Criteria

This trial is for individuals experiencing stress, depression, or anxiety. Participants should be willing to discuss their mental and physical health, attend a therapy session where their brain activity will be measured, and complete follow-up surveys.

Inclusion Criteria

Participants/clients must have no current suicidal ideation in the past month as determined by the Columbia Suicidality Severity Rating Scale
I understand the study procedures and can give informed consent.
My therapist is approved by the study's lead researcher.
See 7 more

Exclusion Criteria

Participants/clients with active, current suicidal ideation as determined by the Columbia-Suicide Severity Rating Scale in the past month
Participants/clients with a past suicide attempt (lifetime)
Participants/clients with anything in the assessment of the study team that will not lead to successful completion of study requirements
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Intervention

Participants attend a single 60-minute psychosocial intervention session receiving either Behavioral Activation or Psychoeducation with simultaneous brain activity measurement

1 day
1 visit (in-person)

Follow-up

Participants complete follow-up surveys to assess changes in depression symptoms and therapeutic alliance

4 weeks
2 visits (virtual)

Treatment Details

Interventions

  • Behavioral Activation
  • Psychoeducation
Trial Overview The study aims to compare the effects of Behavioral Activation (a type of cognitive-behavioral therapy) with Psychoeducation on people with depression symptoms by measuring how well client-therapist brain activities sync during sessions.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Behavioral ActivationExperimental Treatment1 Intervention
Behavioral Activation (BA) is a psychotherapy modality that can be used to treat depression. The 60 minute session of BA is designed to actively engage with the client in creating personalized goals and ways in which maladaptive coping mechanisms maintaining depression can be addressed and replaced with increased exposure to positive reinforcement.
Group II: PsychoeducationActive Control1 Intervention
Psychoeducation will be used in this study as a control condition. The 60 minute session will be structured to provide general educational information on depression and evidence-based strategies to reduce symptoms. The information will be presented in generic format and will not be tailored to be client-specific.

Behavioral Activation is already approved in United States, China, European Union for the following indications:

🇺🇸
Approved in United States as Behavioral Activation Therapy for:
  • Depression
  • Anxiety in older adults undergoing cardiac procedures
🇨🇳
Approved in China as Behavioral Activation Therapy for:
  • Loneliness in older adults
  • Depression
🇪🇺
Approved in European Union as Behavioral Activation Therapy for:
  • Depression
  • Anxiety

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of North Carolina, Chapel Hill

Lead Sponsor

Trials
1,588
Recruited
4,364,000+

Foundation of Hope, North Carolina

Collaborator

Trials
18
Recruited
670+

Findings from Research

A study involving 128 participants with major depressive episodes found that a Health Action Process Approach (HAPA)-based internet-delivered behavioral activation intervention significantly reduced clinician-rated depressive symptoms compared to a control group, with a strong effect size at 8 weeks (d = 0.79).
The intervention group also showed improvements in self-rated depressive symptoms, behavioral activation, and various motivational and volitional outcomes, indicating that the HAPA framework effectively enhances treatment for depression.
Effects of a Web-Based Behavioral Activation Intervention on Depressive Symptoms, Activation, Motivation, and Volition: Results of a Randomized Controlled Trial.Mueller-Weinitschke, C., Bengel, J., Baumeister, H., et al.[2023]
Behavioral Activation (BA) is a well-supported psychotherapy for depression that has evolved over the years, incorporating various techniques such as activity monitoring, scheduling, and skills training, which have empirical support as effective components.
While some techniques like activity scheduling and relaxation training have been validated as effective on their own, others are more effective when used as part of a comprehensive treatment package, highlighting the importance of a tailored approach in BA interventions.
What is behavioral activation? A review of the empirical literature.Kanter, JW., Manos, RC., Bowe, WM., et al.[2022]
Behavioral activation (BA) was effective in reducing symptoms of depression in a preliminary study involving 20 older adults over 5 weeks, indicating its potential as a treatment for vulnerable populations.
Interestingly, the specific types or amounts of activities (functional, pleasurable, or social) did not significantly correlate with symptom improvement, suggesting that simply engaging in activities to counter avoidance may be key to the treatment's effectiveness.
Does Amount and Type of Activity Matter in Behavioral Activation? A Preliminary Investigation of the Relationship between Pleasant, Functional, and Social Activities and Outcome.Hershenberg, R., Paulson, D., Gros, DF., et al.[2015]

References

Effects of a Web-Based Behavioral Activation Intervention on Depressive Symptoms, Activation, Motivation, and Volition: Results of a Randomized Controlled Trial. [2023]
What is behavioral activation? A review of the empirical literature. [2022]
Does Amount and Type of Activity Matter in Behavioral Activation? A Preliminary Investigation of the Relationship between Pleasant, Functional, and Social Activities and Outcome. [2015]
Data-Driven Learning in High-Resolution Activity Sampling From Patients With Bipolar Depression: Mixed-Methods Study. [2020]
A Narrative Review of Empirical Literature of Behavioral Activation Treatment for Depression. [2022]
Toward the Development of a Functional Analysis Risk Assessment Decision Tool. [2021]
Concordance between patient-centered and adaptive behavior outcome measures after applied behavior analysis for autism. [2023]
Using e-learning modules to teach ongoing-visual inspection of functional analyses. [2021]
A Behavioral Safety Model for Clinical Settings: Coaching for Institutionalization. [2023]
Improving Public Perception of Behavior Analysis. [2018]
11.United Statespubmed.ncbi.nlm.nih.gov
Patient experiences with group behavioural activation in a partial hospital program. [2021]
Behavioral activation: Is it the expectation or achievement, of mastery or pleasure that contributes to improvement in depression? [2019]
13.United Statespubmed.ncbi.nlm.nih.gov
Randomized control trial of a culturally adapted behavioral activation therapy for Muslim patients with depression in Pakistan. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security